Year-end Sale % OFF 
Abstract
BackgroundA high prevalence of epilepsy has been observed in many onchocerciasis endemic regions. This study is to estimate the prevalence of active epilepsy and exposure to Onchocerca volvulus infection in a rural population in Ituri province, Democratic Republic of Congo.MethodsIn August 2016, a community-based cross-sectional study was conducted in an onchocerciasis endemic area in the rural health zone of Logo, Ituri Province. Households within two neighbouring health areas were randomly sampled. To identify persons with epilepsy, a three-stage approach was used. In the first stage, all individuals of the selected households were screened for epilepsy by non-medical field workers using a validated 5-item questionnaire. In the second and third stage, suspected cases of epilepsy were examined by non-specialist medical doctors, and by a neurologist, respectively. A case of epilepsy was defined according to the 2014 International League Against Epilepsy (ILAE) guidelines. Exposure to O. volvulus was assessed by testing for IgG4 antibodies to an O. volvulus antigen (OV16 Rapid Test,) in individuals aged 3 years and older.ResultsOut of 1389 participants included in the survey, 64 were considered to have active epilepsy (prevalence 4.6%) (95% confidence interval [CI]: 3.6–5.8). The highest age-specific epilepsy prevalence estimate was observed in those aged 20 to 29 years (8.2%). Median age of epilepsy onset was 10 years, with a peak incidence of epilepsy in the 10 to 15 year-old age group. OV16 test results were available for 912 participants, of whom 30.5% (95% CI, 27.6–33.6) tested positive. The prevalence of OV16 positivity in a village ranged from 8.6 to 68.0%. After adjusting for age, gender and ivermectin use, a significant association between exposure to onchocerciasis and epilepsy was observed (adjusted odds ratio = 3.19, 95% CI: 1.63–5.64) (P < 0.001).ConclusionsA high prevalence of epilepsy and a significant association between epilepsy and exposure to O. volvulus were observed in the population in Ituri province, Democratic Republic of Congo. There is an urgent need to implement a CDTI programme and to scale up an epilepsy treatment and care programme.
Highlights
A high prevalence of epilepsy has been observed in many onchocerciasis endemic regions
In 2016, an estimated 14.6 million people were infected with onchocerciasis worldwide, with over 99% of cases occurring in sub-Saharan Africa [1]
An increased prevalence of epilepsy has been observed in many onchocerciasis endemic areas [4,5,6,7,8], which has led researchers to hypothesize that epilepsy may be another manifestation of onchocerciasis
Summary
A high prevalence of epilepsy has been observed in many onchocerciasis endemic regions. In 2016, an estimated 14.6 million people were infected with onchocerciasis worldwide, with over 99% of cases occurring in sub-Saharan Africa [1]. This includes the Democratic Republic of the Congo (DRC), where onchocerciasis is endemic in all provinces [2]. An increased prevalence of epilepsy has been observed in many onchocerciasis endemic areas [4,5,6,7,8], which has led researchers to hypothesize that epilepsy may be another manifestation of onchocerciasis This is supported by the observation that nodding syndrome, a neurological syndrome characterized by episodes of atonic seizures, only occurs in regions hyperendemic for onchocerciasis [9]
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
